Clinical Trials

10 enrolled

Multiple Myeloma

NCT02280525 2023-06-07

Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma

LymphoidOther hematologic neoplasm

8 enrolled

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02077959 2023-01-27

Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

20 enrolled

Multiple Myeloma

NCT04635683 2022-09-30

Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Phase 1 Withdrawn

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03113695 2022-07-05

Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome

4 enrolled

Tumor-Agnostic

Neoplasms

NCT03302728 2022-05-19

EpiBrentlen

6 enrolled

DermatologicLymphoid

Hodgkin Disease, Recurrence, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT01433965 2022-03-10

Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

MyeloidOther hematologic neoplasm

16 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02086604 2022-02-17

Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma

37 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01218555 2022-01-27

Study of Everolimus (RAD001) in Combination With Lenalidomide

EndocrineGenitourinaryNET

44 enrolled 9 charts

Kidney Neoplasms, Neuroendocrine Tumors

NCT01578954 2022-01-27

Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction

Other hematologic neoplasm

20 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT01038388 2021-11-03

A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple Myeloma

30 enrolled

Multiple Myeloma

NCT01965353 2021-09-05

PanRVD

21 enrolled

Multiple Myeloma

NCT02481934 2021-08-20

NK-VS-MM

5 enrolled 6 charts

Multiple Myeloma

NCT03050450 2021-04-05

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

8 enrolled 10 charts

CNS

Central Nervous System Neoplasms

NCT01207921 2021-03-10

Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma

28 enrolled

Hodgkin Disease

NCT02721043 2021-01-11

Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies

13 enrolled

Tumor-Agnostic

Neoplasms

NCT01246622 2020-09-24

Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Other hematologic neoplasm

32 enrolled

Congenital Abnormalities, Leukemia, Myeloid, Acute

NCT01542918 2020-08-11

Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma

14 enrolled

Lymphoma, Recurrence, Intraocular Lymphoma

NCT03506802 2020-07-24

NYSCT MM

Phase 1 Withdrawn

Multiple Myeloma

NCT00729118 2020-05-18

Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

19 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02492750 2020-03-25

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

14 enrolled 12 charts

Smoldering Multiple Myeloma, Multiple Myeloma

NCT01742793 2020-03-04

RID

LymphoidMyeloidOther hematologic neoplasm

12 enrolled

LymphoidPlasma cell

Hodgkin Disease, Multiple Myeloma, Lymphoma, T-Cell

NCT01619761 2020-02-11

NK Cells in Cord Blood Transplantation

Phase 1 Unknown

13 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02370888 2020-01-27

UF-BMT-MRD-101

MyeloidOther hematologic neoplasm

11 enrolled 3 charts

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT03015922 2020-01-22

MUKeleven

Phase 1 Unknown

4 enrolled

Multiple Myeloma

NCT00840931 2019-12-11

Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)

Other hematologic neoplasm

22 enrolled

Leukemia

NCT01729104 2019-10-22

Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

18 enrolled

Lymphoma, Recurrence, Lymphoma, Mantle-Cell

NCT01429025 2019-10-08

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma

LymphoidOther hematologic neoplasm

26 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00687674 2019-08-20

Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

13 enrolled 7 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03373305 2019-04-30

Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas

Phase 1 Withdrawn

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT03558750 2019-04-25

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

6 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01440582 2019-03-04

Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients

77 enrolled